EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis

Yanqin Bian, Zheng Xiang, Yaofeng Wang, Qing Ren, Guoming Chen, Bei Xiang, Jianye Wang, Chengbo Zhang, Shaoqiang Pei, Shicheng Guo, Lianbo Xiao

Frontiers in Pharmacology · 15.11.2023 · 14

DOI: 10.3389/fphar.2023.1285455 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.11.2023. Verfasst von Yanqin Bian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Arthritis Research in Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic, autoimmune pathology characterized by persistent synovial inflammation and gradually advancing bone destruction. Matrix metalloproteinases (MMPs), as a family of zinc-containing enzymes, have been found to play an important role in degradation and remodeling of extracellular matrix (ECM). MMPs participate in processes of cell proliferation, migration, inflammation, and cell metabolism. A growing number of persons have paid attention to their function in inflammatory and immune diseases. In this review, the details of regulation of MMPs expression and its expression in RA are summarized. The role of MMPs in ECM remodeling, angiogenesis, oxidative and nitrosative stress, cell migration and invasion, cytokine and chemokine production, PANoptosis and bone destruction in RA disease are discussed. Additionally, the review summarizes clinical trials targeting MMPs in inflammatory disease and discusses the potential of MMP inhibition in the therapeutic context of RA. MMPs may serve as biomarkers for drug response, pathology stratification, and precision medicine to improve clinical management of rheumatoid arthritis.

Schlagwörter

Stichwörter der Autor:innen

angiogenesisbone destructionmatrix metalloproteinasesrheumatoid arthritistarget

Autor:innen und Institutionen

  • Institute of Arthritis Research in Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
  • Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Department of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.

Zitieren

APA

Bian, Y., Xiang, Z., Wang, Y., Ren, Q., Chen, G., Xiang, B., Wang, J., Zhang, C., Pei, S., Guo, S., & Xiao, L. (2023). Immunomodulatory roles of metalloproteinases in rheumatoid arthritis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1285455

Vancouver

Bian Y, Xiang Z, Wang Y, Ren Q, Chen G, Xiang B, et al. Immunomodulatory roles of metalloproteinases in rheumatoid arthritis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1285455

BibTeX
@article{Bian2023,
  author = {Bian, Yanqin and Xiang, Zheng and Wang, Yaofeng and Ren, Qing and Chen, Guoming and Xiang, Bei and Wang, Jianye and Zhang, Chengbo and Pei, Shaoqiang and Guo, Shicheng and Xiao, Lianbo},
  title = {Immunomodulatory roles of metalloproteinases in rheumatoid arthritis},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1285455}
}
Kostenlos starten →